Global Information
회사소개 | 문의 | 비교리스트

의약품-의료기기 콤비네이션 제품 시장 : 규모, 점유율, 전망, 기회 분석(2020-2027년) : 제품 유형, 지역별

Drug-Device Combination Products Market, By Product Type, and By Region - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027

리서치사 Coherent Market Insights
발행일 2020년 06월 상품 코드 948358
페이지 정보 영문
가격
US $ 4,500 ₩ 5,293,000 PPT Turned PDF (Single User License)
US $ 7,000 ₩ 8,234,000 PPT Turned PDF (Multi-user License)
US $ 10,000 ₩ 11,763,000 PPT Turned PDF (Enterprise User License)


의약품-의료기기 콤비네이션 제품 시장 : 규모, 점유율, 전망, 기회 분석(2020-2027년) : 제품 유형, 지역별 Drug-Device Combination Products Market, By Product Type, and By Region - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027
발행일 : 2020년 06월 페이지 정보 : 영문

의약품-의료기기 콤비네이션 제품은 특수한 디바이스를 통해 환자에게 투여 또는 전달되는 약물로 구성되어 있습니다. 이와 같은 제품의 예에는 프리필드 시린지, 주입 펌프, 스텐트 등의 약물 코팅 디바이스 등이 포함됩니다.

세계의 의약품-의료기기 콤비네이션 제품 시장에 대해 조사했으며, 시장의 개요, 시장에 영향을 미치는 요인 분석, 각 부문·지역별 시장 분석, 주요 기업의 개요 등을 정리하여 전해드립니다.

제1장 조사 목적·전제조건

제2장 시장 범위

  • 리포트 설명
  • 시장의 정의와 범위
  • 개요
  • 시장 내역 : 제품 유형별
  • Coherent Opportunity Map(COM)

제3장 시장 역학, 규제, 동향 분석

  • 시장 역학
  • 촉진요인
  • 억제요인
  • 시장 기회
  • 영향 분석
  • 주요 발전
  • 기술 진보
  • 규제 시나리오

제4장 세계의 의약품-의료기기 콤비네이션 제품 시장 : 제품 유형별

  • 서론
  • 시장 점유율 분석
  • 전년대비 성장 분석
  • 부문 동향
  • 약물 용출 스텐트
  • 서론
  • 시장 규모와 예측 및 전년대비 성장
  • 부문 동향
  • 관상동맥 스텐트
  • 말초혈관 스텐트
  • 주입 펌프
  • 서론
  • 시장 규모와 예측 및 전년대비 성장
  • 부문 동향
  • 삽입형
  • 외래
  • 광증감제
  • 서론
  • 시장 규모와 예측 및 전년대비 성장
  • 부문 동향
  • 정형외과용 콤비네이션 제품(골이식편 임플란트+항생제 배합 골시멘트)
  • 서론
  • 시장 규모와 예측 및 전년대비 성장
  • 부문 동향
  • 창상관리 배합 상품
  • 서론
  • 시장 규모와 예측 및 전년대비 성장
  • 부문 동향
  • 흡입기
  • 서론
  • 시장 규모와 예측 및 전년대비 성장
  • 부문 동향
  • 네뷸라이저
  • MDI
  • DPI
  • 경피 패치
  • 서론
  • 시장 규모와 예측 및 전년대비 성장
  • 부문 동향
  • 기타(안내 임플란트, 약제용출 비즈)
  • 서론
  • 시장 규모와 예측 및 전년대비 성장
  • 부문 동향

제5장 세계의 의약품-의료기기 콤비네이션 제품 시장 : 지역별

    • 서론
    • 시장 점유율 분석
    • 전년대비 성장 분석
    • 부문 동향
    • 북미
    • 서론
    • 시장 규모와 예측 및 전년대비 성장
    • 미국
    • 캐나다
    • 유럽
    • 서론
    • 시장 규모와 예측 및 전년대비 성장
    • 영국
    • 독일
    • 이탈리아
    • 프랑스
    • 스페인
    • 러시아
    • 기타 유럽
    • 아시아태평양
    • 서론
    • 시장 규모와 예측 및 전년대비 성장
    • 중국
    • 인도
    • 일본
    • ASEAN
    • 호주
    • 한국
    • 기타 아시아태평양
    • 라틴아메리카
    • 서론
    • 시장 규모와 예측 및 전년대비 성장
    • 브라질
    • 멕시코
    • 아르헨티나
    • 기타 라틴아메리카
    • 중동
    • 서론
    • 시장 규모와 예측 및 전년대비 성장
    • GCC
    • 이스라엘
    • 기타 중동
    • 아프리카
    • 서론
    • 시장 규모와 예측 및 전년대비 성장
    • 북아프리카
    • 중앙아프리카
    • 남아프리카

제6장 경쟁 구도

  • 기업 개요
  • Teva Pharmaceutical Industries Ltd.
  • 회사 개요
  • 제품 포트폴리오
  • 주요 발전
  • 재무 실적
  • 전략
  • Becton, Dickinson and Company
  • Integer Holdings Corporation
  • Abbott Laboratories
  • Medtronic plc
  • Allergan, Inc.
  • Alcon, Inc.
  • Arrow International, Inc.
  • Bausch&Lomb, Inc.
  • Boston Scientific Corporation
  • 기타 주요 기업

제7장 섹션

KSA 20.07.28

Title:
Drug-Device Combination Products Market, By Product Type (Drug Eluting Stents (Coronary stent, Peripheral Vascular stents), Infusion pumps (Implantable, Ambulatory), Photosensitizers, Orthopedic combination products (Bone graft imlants + antibiotic loaded bone cements), Wound care combination products, Inhalers (Nebulizers, MDI, DPI), Transdermal patches, Others( Intraocular implants, drug eluting beads)), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East & Africa) - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027.

Drug device combination products consists of drugs administered or delivered through a specialized devices to the patients. Examples of such products include prefilled syringes, infusion pumps, drug coated devices such as stents, and others. Manufacturers such as Teva Pharmaceutical Industries Ltd., Becton, Dickinson and Company, Integer Holdings Corporation, Abbott Laboratories, and others offer drug device combination products in the market.

Restraints of the Global Drug-Device Combination Products Market

Major factors hampering the growth of the drug-device combination products market during the forecast period constitutes of presence of stringent and non-specific regulatory pathway and risks associated with infections.

Key features of the study:

  • This report provides in-depth analysis of the global drug-device combination products market and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2019-2027), considering 2018, as the base year
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by leading players
  • It profiles leading players in the global drug-device combination products market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include Teva Pharmaceutical Industries Ltd., Becton, Dickinson and Company, Integer Holdings Corporation, Abbott Laboratories, Medtronic plc, Allergan, Inc., Alcon, Inc., Arrow International, Inc., Bausch & Lomb, Inc., Boston Scientific Corporation, ALK, SINOMED, Kaleo, Haselmeier, Flowonix Medical, Inc., CareFusion Corporation, and Covidien PLC
  • Insights from this report would allow marketers and the management authorities of companies to make informed decision regarding future product launches, technology up-gradation, market expansion, and marketing tactics
  • The global drug-device combination products market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the market.

Detailed Segmentation

  • Global Drug-Device Combination Products Market, By Product Type:
  • Drug Eluting Stents
  • Coronary stent
  • Peripheral Vascular stents
  • Infusion pumps
  • Implantable
  • Ambulatory
  • Photosensitizers
  • Orthopedic combination products (Bone graft imlants + antibiotic loaded bone cements)
  • Wound care combination products
  • Inhalers
  • Nebulizers
  • MDI
  • DPI
  • Transdermal patches
  • Others( Intraocular implants, drug eluting beads)
  • Global Drug-Device Combination Products Market, By Geography:
  • North America
  • By Product Type
  • Drug Eluting Stents
    • Coronary stent
    • Peripheral Vascular stents
  • Infusion pumps
    • Implantable
    • Ambulatory
  • Photosensitizers
  • Orthopedic combination products (Bone graft imlants + antibiotic loaded bone cements)
  • Wound care combination products
  • Inhalers
    • Nebulizers
    • MDI
    • DPI
  • Transdermal patches
  • Others( Intraocular implants, drug eluting beads
  • By Country:
  • U.S.
  • Canada
  • Europe
  • By Product Type
  • Drug Eluting Stents
    • Coronary stent
    • Peripheral Vascular stents
  • Infusion pumps
    • Implantable
    • Ambulatory
  • Photosensitizers
  • Orthopedic combination products (Bone graft imlants + antibiotic loaded bone cements)
  • Wound care combination products
  • Inhalers
    • Nebulizers
    • MDI
    • DPI
  • Transdermal patches
  • Others( Intraocular implants, drug eluting beads
  • By Country:
  • U.K.
  • Germany
  • Italy
  • France
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
  • By Product Type
  • Drug Eluting Stents
    • Coronary stent
    • Peripheral Vascular stents
  • Infusion pumps
    • Implantable
    • Ambulatory
  • Photosensitizers
  • Orthopedic combination products (Bone graft imlants + antibiotic loaded bone cements)
  • Wound care combination products
  • Inhalers
    • Nebulizers
    • MDI
    • DPI
  • Transdermal patches
  • Others( Intraocular implants, drug eluting beads
  • By Country:
  • China
  • India
  • Japan
  • ASEAN
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • Latin America
  • By Product Type
  • Drug Eluting Stents
    • Coronary stent
    • Peripheral Vascular stents
  • Infusion pumps
    • Implantable
    • Ambulatory
  • Photosensitizers
  • Orthopedic combination products (Bone graft imlants + antibiotic loaded bone cements)
  • Wound care combination products
  • Inhalers
    • Nebulizers
    • MDI
    • DPI
  • Transdermal patches
  • Others( Intraocular implants, drug eluting beads
  • By Country:
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Middle East:
  • By Product Type
  • Drug Eluting Stents
    • Coronary stent
    • Peripheral Vascular stents
  • Infusion pumps
    • Implantable
    • Ambulatory
  • Photosensitizers
  • Orthopedic combination products (Bone graft imlants + antibiotic loaded bone cements)
  • Wound care combination products
  • Inhalers
    • Nebulizers
    • MDI
    • DPI
  • Transdermal patches
  • Others( Intraocular implants, drug eluting beads
  • By Country:
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
  • By Product Type
  • Drug Eluting Stents
    • Coronary stent
    • Peripheral Vascular stents
  • Infusion pumps
    • Implantable
    • Ambulatory
  • Photosensitizers
  • Orthopedic combination products (Bone graft imlants + antibiotic loaded bone cements)
  • Wound care combination products
  • Inhalers
    • Nebulizers
    • MDI
    • DPI
  • Transdermal patches
  • Others( Intraocular implants, drug eluting beads
  • By Country/Region:
  • Central Africa
  • South Africa
  • North Africa
  • Company Profiles
  • Teva Pharmaceutical Industries Ltd.*
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Key Strategies
  • Recent Developments
  • Becton, Dickinson and Company
  • Integer Holdings Corporation
  • Abbott Laboratories
  • Medtronic plc
  • Allergan, Inc.
  • Alcon, Inc.
  • Arrow International, Inc.
  • Bausch & Lomb, Inc.
  • Boston Scientific Corporation
  • Other Major Players

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objective and Assumption

    • Research Objectives
    • Assumptions
    • Abbreviations

2. Market Purview

    • Report Description
    • Market Definition and Scope
    • Executive Summary
    • Market Snippet, By Product Type
    • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

    • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
    • Impact Analysis
    • Key Developments
    • Technological Advancement
    • Regulatory Scenario

4. Global Drug-Device Combination Products Market, By Product Type, 2017 - 2027 (US$ Mn)

    • Introduction
    • Market Share Analysis, 2019 and 2027 (%)
    • Y-o-Y Growth Analysis, 2019-2027
    • Segment Trends
    • Drug Eluting Stents
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019 - 2027, (US$ Mn)
    • Segment Trends
    • Coronary stent
    • Peripheral Vascular stents
    • Infusion pumps
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019 - 2027, (US$ Mn)
    • Segment Trends
    • Implantable
    • Ambulatory
    • Photosensitizers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019 - 2027, (US$ Mn)
    • Segment Trends
    • Orthopedic combination products (Bone graft imlants + antibiotic loaded bone cements)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019 - 2027, (US$ Mn)
    • Segment Trends
    • Wound care combination products
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019 - 2027, (US$ Mn)
    • Segment Trends
    • Inhalers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019 - 2027, (US$ Mn)
    • Segment Trends
    • Nebulizers
    • MDI
    • DPI
    • Transdermal patches
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019 - 2027, (US$ Mn)
    • Segment Trends
    • Others( Intraocular implants, drug eluting beads)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019 - 2027, (US$ Mn)
    • Segment Trends

5. Global Drug-Device Combination Products Market, By Regions, 2017 - 2027 (US$ Mn)

    • Introduction
    • Market Share Analysis, 2019 and 2027 (%)
    • Y-o-Y Growth Analysis, 2019-2027
    • Segment Trends
    • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019 - 2027, (US$ Mn)
    • U.S.
    • Canada
    • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019 - 2027, (US$ Mn)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
    • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019 - 2027, (US$ Mn)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
    • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019 - 2027, (US$ Mn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
    • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019 - 2027, (US$ Mn)
    • GCC
    • Israel
    • Rest of Middle East
    • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019 - 2027, (US$ Mn)
    • North Africa
    • Central Africa
    • South Africa

6. Competitive Landscape

    • Company Profiles
    • Teva Pharmaceutical Industries Ltd.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Becton, Dickinson and Company
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Integer Holdings Corporation
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Abbott Laboratories
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Medtronic plc
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Allergan, Inc.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Alcon, Inc.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Arrow International, Inc.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Bausch & Lomb, Inc.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Boston Scientific Corporation
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Other Major Players
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies

7. Section

    • References
    • Research Methodology
    • About us and Sales Contact
Back to Top
전화 문의
F A Q